Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06449599
Other study ID # 015
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 4, 2024
Est. completion date December 15, 2024

Study information

Verified date June 2024
Source Istanbul University - Cerrahpasa (IUC)
Contact Gozde Altun
Phone +905544290333
Email gozde.altun@iuc.edu.tr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

ICD implantation can be painful procedure even under local anesthesia and sedation. In this prospective-randomised study, ultrasound-guided rhomboid intercostal block will be performed to reduce intraoperative and postoperative pain. Also comfort of patients and the cardiologists will be evaluated. In this way, we expect to reduce possible complications and make this procedure more comfortable for patients and clinicians.


Description:

ICD implantation is mostly performed under local anesthesia(LA).With sedation,the patient's anxiety and pain decrease but complications such as respiratory depression and hemodynamic deterioration may occur due to sedation. Rhomboid intercostal block(RIB) is often applied between the rhomboid major and the intercostal muscle from the midpoint of the medial edge of the scapula.With RIB,cutaneous branches of the thoracic intercostal nerves between T2-T8 are targeted.No studies have been found on the analgesic efficiency of RIB in ICD implantation. Standard procedure will be applied to the control group(C) (n:25).In RIB group(RIBB)(n:25), LA and RIBB will be performed under USG guidance. Patients' demographic data,the vessel used to advance ICD lead,the side where the ICD is placed,ICD battery location(subcutaneous,subfascial,subpectoral),procedure duration, complications seen during the procedure,need for additional analgesics will be recorded.The highest pain level felt during implantation and pain level felt with coughing and at rest at the 3rd, 6th, 12th and 24th postoperative hours will be recorded according to the Numeric Rating Scale-11(NRS -11) scoring system.For patient&physician satisfaction;5-point Likert scale will be used. In the follow-up of RIBB patients, if the patient expresses pain or NRSā‰„4, 1 g acetaminophen will be administered intravenously. In the control group,patients will be administered LA using standard methods.If necessary,in postoperative period 1 g Acetominophen will be given intravenously every 8 hours. Pain occurs especially during venous puncture, surgical incision,opening a pocket for the ICD battery and battery insertion.Although LA is often applied to cover the superficial tissue, puncture areas and pocket areas before the procedure, it may be insufficient to completely eliminate pain.Patients experience instability in intraoperative and postoperative hemodynamics due to pain.Instable hemodynamics in cardiac patients increases the frequency of undesirable cardiac events.With increasing pain,patients move during the operation,the procedure time is prolonged and complications such as bleeding,unwanted vascular injury, surgical incisions and electrode malposition increase.The first aim of the study is to investigate the efficiency of RIB,which is practical to apply with USG and has low complications,in ICD patients.Secondary aim is to investigate patient and physician satisfaction in ICD implantation cases where RIB will be applied.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date December 15, 2024
Est. primary completion date October 15, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - over 18 years of age, - no previous ICD or Pacemaker implantation attempt - ASA ( American Society of Anesthesiologists ) score of 2-3, - INR < 2.0 , - Signing the volunteer consent form, - Patients who met the study criteria will be included in the study. Exclusion Criteria: - Morbidly obese patients (BMI>35 kg/m2), - Advanced decompensated heart failure with New York Heart Association (NYHA) stage 4, - Having severe chronic obstructive pulmonary disease, - Allergy to the prescribed medications , - Those who have a skin infection or lesion in the area to be blocked, - Cannot be communicated and cannot be given a position, - Severe psychosis and progressive neurological deficits and muscle disease, - ICD/ Pacemaker revision or upgrade to be made, - ICD battery replacement - Pregnant patients will be excluded from the study.

Study Design


Intervention

Device:
ultrasound
local anesthesia 400 mg prilocaine (priloc 2%, 20 ml, Vemilac,Türkiye) to surgical field and additionally ultrasound-guided rhomboid intercostal plane block 0,25% bupivacaine 20 ml (Buvasin 0,5%, 20 ml, Vemilac, Türkiye) will be applied to the patients who will be inserted implantable cardioverter defibrillator.
Procedure:
parenteral local anesthesia
only local anesthesia 400 mg prilocaine (priloc 2%, 20 ml, Vemilac,Türkiye) to surgical field will be applied to the patients who will be inserted implantable cardioverter defibrillator.

Locations

Country Name City State
Turkey Istanbul Universtiy Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Istanbul University - Cerrahpasa (IUC)

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary The pain will be assessed by the Numeric Rating Scale-11(NRS -11). Minimum pain score is point zero, maximum pain score is ten points. to measure the analgesic efficacy of RIB 4 months
Primary Investigation patient and physician satisfaction assessed by 5-point Likert scale. One point represents strongly unsatisfied and 5 points represent strongly satisfied. For patient and physician satisfaction;5-point Likert scale will be used. 4 months
See also
  Status Clinical Trial Phase
Completed NCT04633850 - Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
Recruiting NCT03181620 - Sedation Administration Timing: Intermittent Dosing Reduces Time to Extubation N/A
Completed NCT04579354 - Virtual Reality (VR) Tour to Reduce Preoperative Anxiety Before Anaesthesia N/A
Recruiting NCT06007378 - Optimizing Postoperative Pain Control After Laparoscopic Colorectal Surgery N/A
Recruiting NCT05943015 - Analgesic Efficacy of Quadratus Lumborum, Paravertebral Blocks N/A
Completed NCT04544228 - Ketamine or Neostigmine for Serratus Anterior Plane Block in Modified Radical Mastectomy N/A
Completed NCT03678168 - A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries N/A
Completed NCT03286543 - Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System N/A
Completed NCT03663478 - Continuous TQL Block for Elective Cesarean Section Phase 4
Completed NCT04176822 - Designing Animated Movie for Preoperative Period N/A
Completed NCT05170477 - Influence of Apical Patency Concept Upon Postoperative Pain After Root Canal Treatment N/A
Completed NCT06425601 - A Comparison of Silicone Versus Polyvinylchloride (PVC) Drains Following VATS Lobectomy N/A
Not yet recruiting NCT04561856 - Fascia Iliaca Block Supplemented With Perineural Vs Intravenous Dexamethasone Phase 4
Completed NCT03612947 - TAP Block in Laparoscopic Cholecystectomy. Phase 2
Completed NCT05974501 - Pre vs Post Block in Total Knee Arthroplasty (TKA) Phase 4
Completed NCT05995912 - Efficacy and Safety of Etoricoxib-tramadol Tablet in Acute Postoperative Pain Phase 2
Completed NCT04571515 - Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain Phase 2
Active, not recruiting NCT04190355 - The Effect of Irrigant Types Used During Endodontic Treatment on Postoperative Pain N/A
Recruiting NCT05145153 - Incidence of Chronic Pain After Thoracic Surgery
Recruiting NCT03697278 - Monitoring Postoperative Patient-controlled Analgesia (PCA) N/A